|
ZNF318 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.021200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.837400E-04 |
| Normal-vs-Stage2 |
1.010380E-01 |
| Normal-vs-Stage3 |
6.480000E-01 |
| Normal-vs-Stage4 |
2.776100E-03 |
| Stage1-vs-Stage2 |
6.176000E-01 |
| Stage1-vs-Stage3 |
3.016000E-01 |
| Stage1-vs-Stage4 |
6.425400E-01 |
| Stage2-vs-Stage3 |
5.622600E-01 |
| Stage2-vs-Stage4 |
3.732400E-01 |
| Stage3-vs-Stage4 |
2.041200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.503190E-03 |
| Normal-vs-AfricanAmerican |
3.549000E-01 |
| Normal-vs-Asian |
4.002000E-02 |
| Caucasian-vs-AfricanAmerican |
2.487600E-01 |
| Caucasian-vs-Asian |
8.387600E-01 |
| AfricanAmerican-vs-Asian |
5.995800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.99210000000028E-05 |
| Normal-vs-Female |
9.147600E-01 |
| Male-vs-Female |
5.422400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.064200E-03 |
| Normal-vs-Extreme_Weight |
8.014500E-04 |
| Normal-vs-Obese |
1.471040E-01 |
| Normal-vs-Extreme_Obese |
7.335900E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.176000E-01 |
| Normal_Weight-vs-Obese |
2.129200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.327000E-01 |
| Extreme_Weight-vs-Obese |
8.385800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.908600E-01 |
| Obese-vs-Extreme_Obese |
3.461000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.572400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.463570E-01 |
| Normal-vs-Age(61-80Yrs) |
3.015400E-04 |
| Normal-vs-Age(81-100Yrs) |
4.861200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.475200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.061900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.253700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.756200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.911700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.831400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.524100E-03 |
| Normal-VS-Type2 PRCC |
7.680100E-02 |
| Normal-VS-KIRP CIMP |
9.256000E-01 |
| Normal-VS-Unclassified PRCC |
1.467030E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.932000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.611600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.282600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.200600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.213800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.726000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.084600E-03 |
| Normal-vs-N1 |
4.093400E-01 |
| Normal-vs-N2 |
4.820600E-04 |
| N0-vs-N1 |
6.645700E-02 |
| N0-vs-N2 |
4.509600E-01 |
| N1-vs-N2 |
8.916900E-03 |
|
|
